诺和诺德欧股跌5%

Core Viewpoint - Novo Nordisk's stock price fell by 5% following Trump's announcement regarding a reduction in the prices of weight loss medications [1] Company Summary - Novo Nordisk experienced a significant decline in its stock price, dropping 5% in response to the news about potential price reductions for weight loss drugs [1] Industry Summary - The announcement by Trump regarding the lowering of prices for weight loss medications could impact the broader pharmaceutical industry, particularly companies involved in obesity treatments [1]